Natco Pharma

Egenesis Inc. is a biotechnology company focused on gene editing and genome engineering to create human transplantable organs, tissues, and cells. Established in 2015 and headquartered in Cambridge, Massachusetts, with an additional office in New York City, Egenesis aims to address the global organ shortage by developing solid organs and therapeutic cell transplantation solutions for various diseases. The company utilizes a gene editing platform that incorporates techniques such as single-cell cloning and somatic cell nuclear transfer, which are essential for creating human-compatible organ tissues and cells. Egenesis is particularly engaged in advancing programs related to kidney and islet cell transplantation, striving to provide alternative treatment options for patients with life-threatening conditions.

Cellogen Therapeutics is a biotechnology company focused on developing innovative cell therapy-based solutions for the healthcare sector. The company employs advanced cellular engineering techniques and gene therapy to address a range of conditions, including hematological malignancies, solid tumors, and hemoglobinopathies. Through its work, Cellogen Therapeutics aims to provide effective CAR-T cell-based therapies for the treatment of cancer and metabolic diseases, delivering convenient and cost-effective solutions to healthcare providers and patients.

Pee Safe, established in 2013, is a pioneer in personal hygiene products, initially launching the first toilet seat sanitizer. Since its inception, the company has diversified its offerings to include a range of hygiene products such as feminine hygiene items like pads, tampons, and cups, as well as men's intimate hygiene solutions. Additionally, Pee Safe has introduced hand hygiene products under the brand Palm Safe and face masks and mists branded as Pollution Safe. The company emphasizes vegan and cruelty-free practices, catering to consumers who prioritize ethical considerations in their hygiene choices. By focusing on cleanliness and hygiene, Pee Safe has positioned itself as a leader in several personal care sub-categories.

Eyestem is a cell therapy company focused on developing scalable cell replacement therapies for incurable diseases, particularly targeting conditions like age-related macular degeneration (Dry AMD). Founded by a team of experts in clinical trials, cell therapy, and ophthalmology, Eyestem aims to create a robust and consistent cell therapy platform that prioritizes both efficacy and safety. The company is committed to democratizing access to advanced cell therapies, ensuring that these innovative treatments are available to a global population. By collaborating with leaders in the field, Eyestem seeks to drive advancements in cell therapy, enhancing the potential for effective treatments for various debilitating conditions.

Dash Pharmaceuticals is a pharmaceutical company based in New Jersey, specializing in the sales, marketing, and distribution of generic drugs for the United States market. The company is involved in co-developing and licensing pharmaceutical products, which include nutritional and dietary supplements, vitamins, and topical treatments. Dash Pharmaceuticals markets and distributes these products under its own label, offering a variety of dosage forms to meet consumer needs. Through its comprehensive approach, the company aims to enhance access to essential medications and health products within the U.S. healthcare landscape.

CION Cancer Clinics operates a network of day-care cancer treatment centers in Telangana and Andhra Pradesh, focusing on providing precise and individualized care for cancer patients. The clinics offer a range of services including treatment, detection, and awareness of cancer diseases, aimed at empowering patients to take control of their health. By providing essential support services and information, CION Cancer Clinics enables patients to receive not only medical assistance but also companionship and empathy throughout their recovery journey.

PACE Hospitals operates a hospital chain that provides quality care for a wide range of tertiary healthcare services with personalized and ethical next-gen medicare. PACE delivers advanced procedures at a fraction of the international costs through relentless research and innovation. PACE Hospitals focuses on tertiary care services in the field of medical gastroenterology, surgical gastroenterology, hepatology, nephrology, urology, oncology, orthopedics, pulmonology, gynecology, ENT, cardiology, general medicine & diabetology, endocrinology, general surgery, critical care, cosmetic & plastic surgery, dermatology, neurology, neurosurgery, psychiatry, rheumatology, and andrology.